{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:00Z","timestamp":1787022420091,"version":"build-2736575974"},"reference-count":80,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0186","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T18:12:43Z","timestamp":1725473563000},"page":"23-36","source":"Crossref","is-referenced-by-count":10,"title":["A narrative review of long-term inorganic iodine monotherapy for Graves\u2019 disease with a historical relationship between iodine and thyroid"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-5004","authenticated-orcid":false,"given":"Natsuko","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Plummer H (1923) Results of administering iodin to patients having exophthalmic goiter. J Am Med Assoc 80: 1955."},{"key":"2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.1943.02840190008003","volume":"122","author":"EB Astwood","year":"1943","unstructured":"2 Astwood EB (1943) Treatment of hyperthyroidism with thiourea and thiouracil. JAMA 122: 78\u201381.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"3","unstructured":"3 Trousseau A (1868) Lectures on clinical medicine: delivered at the H\u00f4tel-Dieu, Paris translated and edited with notes and appendices by Bazire PV. The New Sydenham Society, London, UK: 586\u2013587."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Thompson WO, Thompson PK, Brailey AG, Cohen AC (1930) Prolonged treatment of exophthalmic goiter by iodine alone. Arch Intern Med 45: 481\u2013502.","DOI":"10.1001\/archinte.1930.00140100003001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Burch HB, Burman KD, Cooper DS (2012) A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease. J Clin Endocrinol Metab 97: 4549\u20134558.","DOI":"10.1210\/jc.2012-2802"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, et al. (2020) Patterns of use, efficacy, and safety of treatment options for patients with Graves\u2019 disease: a nationwide population-based study. Thyroid 30: 357\u2013364.","DOI":"10.1089\/thy.2019.0132"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Watanabe N, Narimatsu H, Noh JY, Yamaguchi T, Kobayashi K, et al. (2012) Antithyroid drug-induced Hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves\u2019 disease. J Clin Endocrinol Metab 97: E49\u2013E53.","DOI":"10.1210\/jc.2011-2221"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Noh JY, Yasuda S, Sato S, Matsumoto M, Kunii Y, et al. (2009) Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab 94: 2806\u20132811.","DOI":"10.1210\/jc.2008-2700"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Okamura K, Sato K, Fujikawa M, Bandai S, Ikenoue H, et al. (2014) Remission after potassium iodide therapy in patients with Graves\u2019 hyperthyroidism exhibiting thionamide-associated side effects. J Clin Endocrinol Metab 99: 3995\u20134002.","DOI":"10.1210\/jc.2013-4466"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Uchida T, Goto H, Kasai T, Komiya K, Takeno K, et al. (2014) Therapeutic effectiveness of potassium iodine in drug-naive patients with Graves\u2019 disease: a single-center experience. Endocrine 47: 506\u2013511.","DOI":"10.1007\/s12020-014-0171-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Honda A, Uchida T, Komiya K, Goto H, Takeno K, et al. (2017) Relationship between the effectiveness of inorganic iodine and the severity of Graves thyrotoxicosis: a retrospective study. Endocr Pract; 23: 1408\u20131413.","DOI":"10.4158\/EP-2017-0044"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Suzuki N, Yoshimura Noh J, Sugisawa C, Hoshiyama A, Hiruma M, et al. (2020) Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves\u2019 disease. Endocr J 67: 631\u2013638.","DOI":"10.1507\/endocrj.EJ19-0379"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Okamura K, Sato K, Fujikawa M, Bandai S, Ikenoue H, et al. (2022) Iodide-sensitive Graves\u2019 hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment. Endocr J 69: 983\u2013997.","DOI":"10.1507\/endocrj.EJ21-0436"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 van Geest FS, Groeneweg S, Visser WE (2021) Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment. Endocrine 71: 689\u2013695.","DOI":"10.1007\/s12020-020-02603-y"},{"key":"15","unstructured":"15 Kopp PA (2020) Thyroid pathophysiology and diagnostic evaluation. In: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ (eds) Williams Textbook of Endocrinology (14th). Elsevier, Philadelphia, USA: 332\u2013363."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Zimmermann MB (2008) Research on iodine deficiency and goiter in the 19th and early 20th centuries. J Nutr 138: 2060\u20132063.","DOI":"10.1093\/jn\/138.11.2060"},{"key":"17","unstructured":"17 Coindet JF (1820) De\u2019couverte d\u2019un nouveau rem\u00e8de contre le go\u00eetre. Ann Chim Phys 15: 49\u201359 (In French)."},{"key":"18","unstructured":"18 Chatin A (1851) Freshwater iodine research; the presence of this body in plants and terrestrial animals. C R Acad Sci Paris 31: 280\u2013283 (In French)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Marine D (1954) Endemic goiter: a problem in preventive medicine. Ann Intern Med 41: 875\u2013886.","DOI":"10.7326\/0003-4819-41-5-875"},{"key":"20","unstructured":"20  (2021) Global scorecard of iodine nutrition in 2021. Iodine Global Network. https:\/\/ign.org\/app\/uploads\/2023\/04\/IGN_Global_Scorecard_MAP_2021_SAC_-_7_May_2021.pdf accessed on January 6, 2024."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Wolff J (1969) Iodide goiter and the pharmacologic effects of excess iodide. Am J Med 47: 101\u2013124.","DOI":"10.1016\/0002-9343(69)90245-9"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22 Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG (2001) Iodine-Induced hypothyroidism. Thyroid 11: 501\u2013510.","DOI":"10.1089\/105072501300176462"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Suzuki H, Higuchi T, Sawa K, Ohtaki S, Horiuchi Y (1965) \u201cEndemic coast goitre\u201d in Hokkaido, Japan. Acta Endocrinol (Copenh) 50: 161\u2013176.","DOI":"10.1530\/acta.0.0500161"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Zava TT, Zava DT (2011) Assessment of Japanese iodine intake based on seaweed consumption in Japan: A literature-based analysis. Thyroid Res 4: 14.","DOI":"10.1186\/1756-6614-4-14"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Fuse Y, Ito Y, Shishiba Y, Irie M (2022) Current iodine status in Japan: a cross-sectional nationwide survey of schoolchildren, 2014\u20132019. J Clin Endocrinol Metab 107: e2065\u2013e2079.","DOI":"10.1210\/clinem\/dgab919"},{"key":"26","unstructured":"26  (2001) Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Institute of Medicine (US) Panel on Micronutrients. National Academy Press, Washington DC, USA. https:\/\/nap.nationalacademies.org\/read\/10026 accessed on January 6, 2024."},{"key":"27","unstructured":"27  (2006) Tolerable upper intake levels for vitamins and minerals. European Food Safety Authority. https:\/\/www.efsa.europa.eu\/sites\/default\/files\/assets\/ndatolerableuil.pdf accessed on January 6, 2024."},{"key":"28","unstructured":"28  (2020) Report of the Study Group on the Formulation of the Dietary Intake Standards for Japanese (2020 Edition). https:\/\/www.mhlw.go.jp\/stf\/newpage_08517.html accessed on January 6, 2024 (In Japanese)."},{"key":"29","unstructured":"29 Kocher T (1910) Ueber Jodbasedow. Arch Klin Chir 92: 1166\u20131193 (In German)."},{"key":"30","unstructured":"30 Von Basedow KA (1840) Exophthalmos durch Hypertrophie des Zillgewebes in der Augenhohle. Wochenschr Helik 6: 197\u2013204; 220\u2013228 (In German)."},{"key":"31","unstructured":"31 Graves RJ (1835) Newly observed affection of the thyroid gland in females. Lond Med Surg J 7: 516\u2013520."},{"key":"32","unstructured":"32 Plummer HS, Boothby WM (1924) The Value of iodine in exophthalmic goiter. J Iowa State Med Soc 14: 66\u201373."},{"key":"33","unstructured":"33 Plummer HS (1926) The results of iodin administration in exophthalmic goiter. Trans Am Surg Assoc 42: 541\u2013556."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Thompson WO, Brailey AG, Thompson PK (1928) The effective range of iodine dosage in exophthalmic goiter. JAMA 91: 1719.","DOI":"10.1001\/jama.1928.92700220002013a"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Thompson WO, Brailey AG, Thompson PK, Thorp EG (1930) The range of effective iodine dosage in exophthalmic goiter: I. The effect on basal metabolism of rest and of the daily administration of one drop of compound solution of iodine. Arch Intern Med (Chic) 45: 261\u2013281.","DOI":"10.1001\/archinte.1930.00140080103008"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Thompson WO, Thorp EG, Brailey AG, Thompson PK, Cohen AC (1930) The range of effective iodine dosage in exophthalmic goiter: II. The effect on basal metabolism of rest and of the daily administration of one-half drop of compound solution of iodine. Arch Intern Med (Chic) 45: 420\u2013429.","DOI":"10.1001\/archinte.1930.00140090103006"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Thompson WO, Cohen AC, Thompson PK, Thorp EG, Brailey AG (1930) The range of effective iodine dosage in exophthalmic goiter: III. The effect on basal metabolism of rest and of the daily administration of one-quarter drop of compound solution of iodine and of slightly smaller doses, with a summary of results to date. <i>Arch Intern Med (Chic)<\/i> 45: 430\u2013455.","DOI":"10.1001\/archinte.1930.00140090113007"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Thompson WO, Thompson PK, Cohen AC (1932) The range of effective iodine dosage in exophthalmic goiter: IV. The effect on basal metabolism of rest and of the daily administration of about 0.75 mg of iodine. Arch Intern Med (Chic) 49: 199\u2013214.","DOI":"10.1001\/archinte.1932.00150090029004"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Nagataki S, Shizume K, Nakao K (1970) Effect of iodide on thyroidal iodine turnover in hyperthyroid subjects. J Clin Endocrinol Metab 30: 469\u2013478.","DOI":"10.1210\/jcem-30-4-469"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Wolff J, Chaikoff IL (1948) Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174: 555\u2013564.","DOI":"10.1016\/S0021-9258(18)57335-X"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Burgi H (2010) Iodine excess. Best Pract Res Clin Endocrinol Metab 24: 107\u2013115.","DOI":"10.1016\/j.beem.2009.08.010"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Corvilain B, Van Sande J, Dumont JE (1988) Inhibition by iodide of iodide binding to proteins: the \u201cWolff-Chaikoff\u201d effect is caused by inhibition of H2O2 generation. Biochem Biophys Res Commun 154: 1287\u20131292.","DOI":"10.1016\/0006-291X(88)90279-3"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Uyttersprot N, Pelgrims N, Carrasco N, Gervy C, Maenhaut C, et al. (1997) Moderate doses of iodide <i>in vivo<\/i> inhibit cell proliferation and the expression of thyroperoxidase and Na<sup>+<\/sup>\/I-symporter mRNAs in dog thyroid. Mol Cell Endocrinol 131: 195\u2013203.","DOI":"10.1016\/S0303-7207(97)00108-1"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Ohayon R, Boeynaems JM, Braekman JC, Van den Bergen H, Gorin Y, et al. (1994) Inhibition of thyroid NADPH-oxidase by 2-iodohexadecanal in a cell-free system. Mol Cell Endocrinol 99: 133\u2013141.","DOI":"10.1016\/0303-7207(94)90156-2"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Rossich LE, Thomasz L, Nicola JP, Nazar M, Salvarredi LA, et al. (2016) Effects of 2-iodohexadecanal in the physiology of thyroid cells. Mol Cell Endocrinol 437: 292\u2013301.","DOI":"10.1016\/j.mce.2016.08.036"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46 Burgi H, Radvila A, Kohler H, Studer H (1974) Effects of pharmacological doses of iodide on the hyperplastic rat thyroid gland. Roles of intrathyroidal iodide, thyrotropin and thyroglobulin in the Wolff-Chaikoff phenomenon. Endocrinology 95: 388\u2013396.","DOI":"10.1210\/endo-95-2-388"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47 Eng PH, Cardona GR, Fang SL, Previti M, Alex S, et al. (1999) Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium\/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140: 3404\u20133410.","DOI":"10.1210\/en.140.8.3404"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Serrano-Nascimento C, Calil-Silveira J, Nunes MT (2010) Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration. Am J Physiol Cell Physiol 298: C893\u2013C899.","DOI":"10.1152\/ajpcell.00224.2009"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Serrano-Nascimento C, Nicola JP, Teixeira Sda S, Poyares LL, Lellis-Santos C, et al. (2016) Excess iodide downregulates Na(<sup>+<\/sup>)\/I(<sup>\u2013<\/sup>) symporter gene transcription through activation of PI3K\/Akt pathway. Mol Cell Endocrinol 426: 73\u201390.","DOI":"10.1016\/j.mce.2016.02.006"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Calil-Silveira J, Serrano-Nascimento C, Nunes MT (2012) Iodide treatment acutely increases pendrin (SLC26A4) mRNA expression in the rat thyroid and the PCCl3 thyroid cell line by transcriptional mechanisms. Mol Cell Endocrinol 350: 118\u2013124.","DOI":"10.1016\/j.mce.2011.12.002"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51 Nagataki S, Shizume K, Nakao K (1970) Alterations in intrathyroidal iodine metabolism in response to chronic iodide administration. Endocrinology 87: 1218\u20131227.","DOI":"10.1210\/endo-87-6-1218"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Solis SJ, Villalobos P, Orozco A, Delgado G, Quintanar-Stephano A, et al. (2011) Inhibition of intrathyroidal dehalogenation by iodide. J Endocrinol 208: 89\u201396.","DOI":"10.1677\/JOE-10-0300"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Goldsmith RE, Eisele ML (1956) The effect of iodide on the release of thyroid hormone in hyperthyroidism. J Clin Endocrinol Metab 16: 130\u2013137.","DOI":"10.1210\/jcem-16-1-130"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Wartofsky L, Ransil BJ, Ingbar SH (1970) Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest 49: 78\u201386.","DOI":"10.1172\/JCI106225"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Lamas L, Ingbar SH (1978) The effect of varying iodine content on the susceptibility of thyroglobulin to hydrolysis by thyroid acid protease. Endocrinology 102: 188\u2013197.","DOI":"10.1210\/endo-102-1-188"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Lebsir D, Manens L, Grison S, Lestaevel P, Ebrahimian T, et al. (2018) Effects of repeated potassium iodide administration on genes involved in synthesis and secretion of thyroid hormone in adult male rat. Mol Cell Endocrinol 474: 119\u2013126.","DOI":"10.1016\/j.mce.2018.02.017"},{"key":"57","doi-asserted-by":"publisher","unstructured":"57 Uchida T, Shimamura M, Taka H, Kaga N, Miura Y, et al. (2023) The effect of long-term inorganic iodine on intrathyroidal iodothyronine content and gene expression in mice with Graves\u2019 hyperthyroidism. Thyroid 33: 330\u2013337.","DOI":"10.1089\/thy.2022.0496"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Erbil Y, Ozluk Y, Giris M, Salmaslioglu A, Issever H, et al. (2007) Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves\u2019 disease. J Clin Endocrinol Metab 92: 2182\u20132189.","DOI":"10.1210\/jc.2007-0229"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Huang SM, Liao WT, Lin CF, Sun HS, Chow NH (2016) Effectiveness and mechanism of preoperative lugol solution for reducing thyroid blood flow in patients with euthyroid Graves\u2019 disease. World J Surg 40: 505\u2013509.","DOI":"10.1007\/s00268-015-3298-8"},{"key":"60","doi-asserted-by":"publisher","unstructured":"60 Calissendorff J, Falhammar H (2017) Lugol\u2019s solution and other iodide preparations: perspectives and research directions in Graves\u2019 disease. Endocrine 58: 467\u2013473.","DOI":"10.1007\/s12020-017-1461-8"},{"key":"61","doi-asserted-by":"publisher","unstructured":"61 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, et al. (2016) 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26: 1343\u20131421.","DOI":"10.1089\/thy.2016.0229"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Yabuta T, Ito Y, Hirokawa M, Fukushima M, Inoue H, et al. (2009) Preoperative administration of excess iodide increases thyroid volume of patients with Graves\u2019 disease. Endocr J 56: 371\u2013375.","DOI":"10.1507\/endocrj.K08E-240"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Mercier F, Bonal M, Fanget F, Maillard L, Laplace N, et al. (2018) Does surgery without Lugol\u2019s solution pretreatment for Graves\u2019 disease increase surgical morbidity? World J Surg 42: 2123\u20132126.","DOI":"10.1007\/s00268-017-4443-3"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Otsuka F, Noh JY, Chino T, Shimizu T, Mukasa K, et al. (2012) Hepatotoxicity and cutaneous reactions after antithyroid drug administration. Clin Endocrinol (Oxf) 77: 310\u2013315.","DOI":"10.1111\/j.1365-2265.2012.04365.x"},{"key":"65","doi-asserted-by":"publisher","unstructured":"65 Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, et al. (2009) Methimazole-induced agranulocytosis in patients with Graves\u2019 disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid 19: 559\u2013563.","DOI":"10.1089\/thy.2008.0364"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Takata K, Amino N, Kubota S, Sasaki I, Nishihara E, et al. (2010) Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves\u2019 disease. Clin Endocrinol (Oxf) 72: 845\u2013850.","DOI":"10.1111\/j.1365-2265.2009.03745.x"},{"key":"67","doi-asserted-by":"publisher","unstructured":"67 Sato S, Noh JY, Sato S, Suzuki M, Yasuda S, et al. (2015) Comparison of efficacy and adverse effects between methimazole 15 mg + inorganic iodine 38 mg\/day and methimazole 30 mg\/day as initial therapy for Graves\u2019 disease patients with moderate to severe hyperthyroidism. Thyroid 25: 43\u201350.","DOI":"10.1089\/thy.2014.0084"},{"key":"68","unstructured":"68 The Japan Thyroid Association (ed) (2006) Guideline for the treatment of Graves\u2019 disease with antithyroid drug in Japan. Nankodo, Tokyo, Japan (In Japanese)."},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Watanabe N, Yoshimura Noh J, Akamizu T, Yamada M (2022) Survey of the actual administration of thiamazole for hyperthyroidism in Japan by the Japan Thyroid Association. Endocr J 69: 35\u201343.","DOI":"10.1507\/endocrj.EJ21-0238"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Okamura K, Taurog A, Krulich L (1981) Hypothyroidism in severely iodine-deficient rats. Endocrinology 109: 464\u2013468.","DOI":"10.1210\/endo-109-2-464"},{"key":"71","doi-asserted-by":"publisher","unstructured":"71 Inoue K, Taurog A (1968) Acute and chronic effects of iodide on thyroid radioiodine metabolism in iodine-deficient rats. Endocrinology 83: 279\u2013290.","DOI":"10.1210\/endo-83-2-279"},{"key":"72","doi-asserted-by":"publisher","unstructured":"72 Malandrino P, Russo M, Ronchi A, Moretti F, Giani F, et al. (2020) Concentration of metals and trace elements in the normal human and rat thyroid: comparison with muscle and adipose tissue and volcanic <i>versus<\/i> control areas. Thyroid 30: 290\u2013299.","DOI":"10.1089\/thy.2019.0244"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73 Wang B, He W, Li Q, Jia X, Yao Q, et al. (2019) U-shaped relationship between iodine status and thyroid autoimmunity risk in adults. Eur J Endocrinol 181: 255\u2013266.","DOI":"10.1530\/EJE-19-0212"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74 Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K (1992) Effects of iodine on thyroid status of fetus <i>versus<\/i> mother in treatment of Graves\u2019 disease complicated by pregnancy. J Clin Endocrinol Metab 75: 738\u2013744.","DOI":"10.1210\/jcem.75.3.1517362"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75 Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, et al. (2015) Substituting potassium iodide for methimazole as the treatment for Graves\u2019 disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan. Thyroid 25: 1155\u20131161.","DOI":"10.1089\/thy.2014.0581"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76 Yoshihara A, Noh JY, Watanabe N, Kunii Y, Suzuki M, et al. (2020) Characteristics of patients with Graves\u2019 disease whose thyroid hormone levels increase after substituting potassium iodide for methimazole in the first trimester of pregnancy. Thyroid 30: 451\u2013456.","DOI":"10.1089\/thy.2019.0392"},{"key":"77","unstructured":"77 Zabkova K, Kratky J, Jiskra J, Vitkova H (2021) The importance of iodine nutrition during pregnancy - clinical aspect. Cas Lek Cesk 160: 224\u2013228."},{"key":"78","doi-asserted-by":"publisher","unstructured":"78 Emder PJ, Jack MM (2011) Iodine-induced neonatal hypothyroidism secondary to maternal seaweed consumption: a common practice in some Asian cultures to promote breast milk supply. J Paediatr Child Health 47: 750\u2013752.","DOI":"10.1111\/j.1440-1754.2010.01972.x"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79 Hamada K, Mizokami T, Maruta T, Higashi K, Konishi K, et al. (2017) Effects of inorganic iodine therapy administered to lactating mothers with Graves disease on infant thyroid function. J Endocr Soc 1: 1293\u20131300.","DOI":"10.1210\/js.2017-00297"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80 Hamada K, Mizokami T, Maruta T, Higashi K, Konishi K, et al. (2021) Thyroid function of infants breastfed by mothers with Graves disease treated with inorganic iodine: a study of 100 cases. J Endocr Soc 5: bvaa187.","DOI":"10.1210\/jendso\/bvaa187"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0186\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T22:35:22Z","timestamp":1736548522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0186\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0186","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0186"}}